doi: 10.1128/AAC.40.1.271.
Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate
Affiliations
- PMID: 8787923
- PMCID: PMC163100
- DOI: 10.1128/AAC.40.1.271
Item in Clipboard
Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate
Antimicrob Agents Chemother.
1996 Jan.
Abstract
Ingenol 3,5,20-triacetate (ITA), one of the ingenol derivatives, is a selective inhibitor of human immunodeficiency virus (HIV) replication in vitro. ITA inhibited the replication of HIV strains in MT-4 cells at concentrations of 0.051 to 0.65 microM. This concentration was approximately 10(3)-fold lower than its cytotoxic threshold. The mechanism of action of ITA is primarily attributed to the inhibition of viral adsorption to the host cells, but it is distinct from the mechanism of inhibition by other adsorption inhibitors.
Similar articles
-
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5286-90. doi: 10.1073/pnas.89.12.5286. Proc Natl Acad Sci U S A. 1992. PMID: 1608936 Free PMC article.
-
Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.Antimicrob Agents Chemother. 1990 Jan;34(1):134-8. doi: 10.1128/AAC.34.1.134. Antimicrob Agents Chemother. 1990. PMID: 2327749 Free PMC article.
-
Upregulation of HIV-1 replication in chronically infected cells by ingenol derivatives.Arch Virol. 1998;143(10):2003-10. doi: 10.1007/s007050050436. Arch Virol. 1998. PMID: 9856087
-
Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus.Proc Soc Exp Biol Med. 1991 May;197(1):59-66. doi: 10.3181/00379727-197-43225. Proc Soc Exp Biol Med. 1991. PMID: 1708503
-
HIV proteinase inhibitors.Biochem Soc Trans. 1992 May;20(2):513-6. doi: 10.1042/bst0200513. Biochem Soc Trans. 1992. PMID: 1397651 Review. No abstract available.
Cited by
-
Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.PLoS One. 2014 May 14;9(5):e97257. doi: 10.1371/journal.pone.0097257. eCollection 2014. PLoS One. 2014. PMID: 24827152 Free PMC article.
-
Novel Latency Reversal Agents for HIV-1 Cure.Annu Rev Med. 2018 Jan 29;69:421-436. doi: 10.1146/annurev-med-052716-031710. Epub 2017 Nov 3. Annu Rev Med. 2018. PMID: 29099677 Free PMC article. Review.
-
Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency.AIDS Res Hum Retroviruses. 2015 Jan;31(1):4-12. doi: 10.1089/AID.2014.0199. AIDS Res Hum Retroviruses. 2015. PMID: 25287643 Free PMC article. Review.
-
Ingenol Protects Human T Cells From HIV-1 Infection.Osong Public Health Res Perspect. 2011 Sep;2(2):109-14. doi: 10.1016/j.phrp.2011.07.001. Epub 2011 Aug 3. Osong Public Health Res Perspect. 2011. PMID: 24159460 Free PMC article.
-
Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.AIDS. 2014 Jul 17;28(11):1555-66. doi: 10.1097/QAD.0000000000000289. AIDS. 2014. PMID: 24804860 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
